Literature DB >> 35755487

Distribution Theory Following Blinded and Unblinded Sample Size Re-estimation under Parametric Models.

Sergey Tarima1, Nancy Flournoy2.   

Abstract

Asymptotic distribution theory for maximum likelihood estimators under fixed alternative hypotheses is reported in the literature even though the power of any realistic test converges to one under fixed alternatives. Under fixed alternatives, authors have established that nuisance parameter estimates are inconsistent when sample size re-estimation (SSR) follows blinded randomization. These results have helped to inhibit the use of SSR. In this paper, we argue for local alternatives to be used instead of fixed alternatives. Motivated by Gould and Shih (1998), we treat unavailable treatment assignments in blinded experiments as missing data and rely on single imputation from marginal distributions to fill in for missing data. With local alternatives, it is sufficient to proceed only with the first step of the EM algorithm mimicking imputation under the null hypothesis. Then, we show that blinded and unblinded estimates of the nuisance parameter σ θ 2 are consistent, and re-estimated sample sizes converge to their locally asymptotically optimal values. This theoretical finding is confirmed through Monte-Carlo simulation studies. Practical utility is illustrated through a multiple logistic regression example. We conclude that, for hypothesis testing with a predetermined minimally clinically relevant local effect size, both blinded and unblinded SSR procedures lead to similar sample sizes and power.

Entities:  

Keywords:  adaptive design; asymptotic distribution theory; blinded data; local alternatives; maximum likelihood estimation

Year:  2019        PMID: 35755487      PMCID: PMC9216189          DOI: 10.1080/03610918.2019.1692030

Source DB:  PubMed          Journal:  Commun Stat Simul Comput        ISSN: 0361-0918            Impact factor:   1.162


  13 in total

1.  Modification of sample size in group sequential clinical trials.

Authors:  L Cui; H M Hung; S J Wang
Journal:  Biometrics       Date:  1999-09       Impact factor: 2.571

2.  Estimation in flexible two stage designs.

Authors:  Werner Brannath; Franz König; Peter Bauer
Journal:  Stat Med       Date:  2006-10-15       Impact factor: 2.373

3.  Adaptive designs for confirmatory clinical trials.

Authors:  Frank Bretz; Franz Koenig; Werner Brannath; Ekkehard Glimm; Martin Posch
Journal:  Stat Med       Date:  2009-04-15       Impact factor: 2.373

4.  Modifying the design of ongoing trials without unblinding.

Authors:  A L Gould; W J Shih
Journal:  Stat Med       Date:  1998-01-15       Impact factor: 2.373

5.  Conditional estimation in two-stage adaptive designs.

Authors:  Per Broberg; Frank Miller
Journal:  Biometrics       Date:  2017-01-18       Impact factor: 2.571

6.  Sample size re-estimation for clinical trials with longitudinal negative binomial counts including time trends.

Authors:  Thomas Asendorf; Robin Henderson; Heinz Schmidli; Tim Friede
Journal:  Stat Med       Date:  2018-12-21       Impact factor: 2.373

7.  Blinded sample size recalculation in clinical trials with binary composite endpoints.

Authors:  Anja Sander; Geraldine Rauch; Meinhard Kieser
Journal:  J Biopharm Stat       Date:  2016-06-13       Impact factor: 1.051

8.  Sample size re-estimation incorporating prior information on a nuisance parameter.

Authors:  Tobias Mütze; Heinz Schmidli; Tim Friede
Journal:  Pharm Stat       Date:  2017-11-27       Impact factor: 1.894

9.  Asymptotic properties of maximum likelihood estimators with sample size recalculation.

Authors:  Sergey Tarima; Nancy Flournoy
Journal:  Stat Pap (Berl)       Date:  2019-02-28       Impact factor: 2.234

10.  Precision of maximum likelihood estimation in adaptive designs.

Authors:  Alexandra Christine Graf; Georg Gutjahr; Werner Brannath
Journal:  Stat Med       Date:  2015-10-12       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.